Mometasone Furoate Solution
Product Images NDC 45802-118

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mometasone Furoate (NDC 45802-118). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5d8-chemical-structure (5d8 Chemical Structure)

Chemical structure of Mometasone Furoate showing its steroid backbone with chlorine, hydroxyl, and other functional groups, including a furoate ester moiety.*

FDA Label Image

Image 01

Packaging label for Mometasone Furoate Topical Solution USP 0.1%, 60 mL (55 g) bottle. The label includes instructions for dermatologic use only with no ophthalmic application. It is manufactured by Perrigo and distributed by Padagis Israel Pharmaceuticals Ltd, with storage instructions and ingredient information visible.*

FDA Label Image

Serialization Template

A rectangular label area with placeholders for serial number (S/N), lot number, and expiration date (Exp) of the product. The text instructs to insert the product's serial number, lot number, and expiration date in the designated spaces.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.